Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dipeptidyl-Peptidase IV Inhibitors | 24 | 2024 | 292 | 9.920 |
Why?
|
Diabetes Mellitus, Type 2 | 61 | 2024 | 11695 | 6.550 |
Why?
|
Hypoglycemic Agents | 47 | 2024 | 2866 | 6.180 |
Why?
|
Metformin | 8 | 2023 | 829 | 3.090 |
Why?
|
Sulfonylurea Compounds | 11 | 2024 | 204 | 2.560 |
Why?
|
Cardiovascular Diseases | 26 | 2024 | 15108 | 2.490 |
Why?
|
Propensity Score | 23 | 2021 | 1771 | 2.140 |
Why?
|
Benzhydryl Compounds | 5 | 2024 | 840 | 1.820 |
Why?
|
Heart Failure | 21 | 2024 | 10856 | 1.740 |
Why?
|
Medicare | 29 | 2024 | 6532 | 1.680 |
Why?
|
Glucosides | 5 | 2024 | 446 | 1.610 |
Why?
|
Pregnancy Complications | 15 | 2020 | 2861 | 1.530 |
Why?
|
Abnormalities, Drug-Induced | 6 | 2020 | 316 | 1.520 |
Why?
|
Diabetic Ketoacidosis | 4 | 2023 | 247 | 1.480 |
Why?
|
United States | 81 | 2024 | 69693 | 1.390 |
Why?
|
Anticonvulsants | 8 | 2021 | 1914 | 1.360 |
Why?
|
Cohort Studies | 64 | 2024 | 40450 | 1.330 |
Why?
|
Diabetes Mellitus | 12 | 2023 | 5724 | 1.330 |
Why?
|
Myocardial Infarction | 13 | 2023 | 11690 | 1.290 |
Why?
|
Drug Prescriptions | 10 | 2020 | 1636 | 1.140 |
Why?
|
Renal Insufficiency, Chronic | 8 | 2023 | 2195 | 1.130 |
Why?
|
Stroke | 14 | 2024 | 9963 | 1.120 |
Why?
|
Glucose | 16 | 2024 | 4391 | 1.100 |
Why?
|
Sodium | 10 | 2024 | 1627 | 1.090 |
Why?
|
Fractures, Bone | 4 | 2023 | 1945 | 1.030 |
Why?
|
Glucagon-Like Peptide 1 | 7 | 2023 | 334 | 0.990 |
Why?
|
Diabetic Angiopathies | 2 | 2020 | 820 | 0.960 |
Why?
|
Urinary Tract Infections | 2 | 2019 | 786 | 0.900 |
Why?
|
Aged | 71 | 2024 | 162944 | 0.900 |
Why?
|
Pregnancy Trimester, First | 7 | 2020 | 851 | 0.890 |
Why?
|
Drug Utilization | 4 | 2019 | 1181 | 0.890 |
Why?
|
Atherosclerosis | 3 | 2024 | 3428 | 0.870 |
Why?
|
Nephrolithiasis | 1 | 2024 | 110 | 0.860 |
Why?
|
Analgesics, Opioid | 10 | 2021 | 3667 | 0.850 |
Why?
|
Pharmacoepidemiology | 7 | 2023 | 323 | 0.810 |
Why?
|
Hospital Mortality | 7 | 2021 | 5310 | 0.800 |
Why?
|
Humans | 160 | 2024 | 742088 | 0.800 |
Why?
|
Databases, Factual | 23 | 2022 | 7716 | 0.790 |
Why?
|
Anesthesia, Conduction | 2 | 2014 | 238 | 0.780 |
Why?
|
Research Design | 9 | 2023 | 5979 | 0.760 |
Why?
|
Blood Glucose | 5 | 2023 | 6249 | 0.740 |
Why?
|
Antipsychotic Agents | 10 | 2019 | 3058 | 0.730 |
Why?
|
Opioid-Related Disorders | 7 | 2020 | 2062 | 0.710 |
Why?
|
Perioperative Care | 3 | 2016 | 997 | 0.700 |
Why?
|
Lithium Compounds | 2 | 2019 | 225 | 0.680 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 2017 | 109 | 0.650 |
Why?
|
Female | 97 | 2024 | 379592 | 0.650 |
Why?
|
Hypoglycemia | 2 | 2023 | 859 | 0.640 |
Why?
|
Data Mining | 5 | 2021 | 537 | 0.640 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2020 | 2407 | 0.630 |
Why?
|
Anti-Obesity Agents | 1 | 2021 | 215 | 0.610 |
Why?
|
Comparative Effectiveness Research | 6 | 2023 | 681 | 0.600 |
Why?
|
Adult | 58 | 2024 | 213712 | 0.600 |
Why?
|
Anesthesia, General | 2 | 2014 | 1164 | 0.580 |
Why?
|
Middle Aged | 54 | 2024 | 213127 | 0.570 |
Why?
|
Stomach Ulcer | 1 | 2017 | 125 | 0.570 |
Why?
|
Cause of Death | 5 | 2020 | 3571 | 0.550 |
Why?
|
Influenza Vaccines | 1 | 2023 | 733 | 0.550 |
Why?
|
Hip Fractures | 2 | 2014 | 954 | 0.540 |
Why?
|
Drug Therapy, Combination | 8 | 2021 | 6483 | 0.540 |
Why?
|
Vitamin K | 1 | 2018 | 294 | 0.530 |
Why?
|
Male | 73 | 2024 | 349538 | 0.530 |
Why?
|
Cleft Palate | 2 | 2018 | 558 | 0.530 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1167 | 0.520 |
Why?
|
Incretins | 1 | 2016 | 88 | 0.520 |
Why?
|
Insurance Claim Review | 5 | 2021 | 720 | 0.490 |
Why?
|
Brain Ischemia | 3 | 2021 | 3258 | 0.490 |
Why?
|
Lithium | 1 | 2017 | 601 | 0.480 |
Why?
|
Heart Defects, Congenital | 6 | 2018 | 4566 | 0.480 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2023 | 1239 | 0.480 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3239 | 0.480 |
Why?
|
Hospitalization | 12 | 2023 | 10232 | 0.470 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5019 | 0.470 |
Why?
|
Pain, Postoperative | 3 | 2021 | 1638 | 0.460 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1205 | 0.450 |
Why?
|
Myocardial Revascularization | 2 | 2018 | 841 | 0.440 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.440 |
Why?
|
Risk | 10 | 2020 | 9679 | 0.430 |
Why?
|
Bronchodilator Agents | 4 | 2016 | 502 | 0.410 |
Why?
|
Blood Coagulation | 1 | 2018 | 1126 | 0.410 |
Why?
|
Risk Factors | 27 | 2023 | 72145 | 0.410 |
Why?
|
Kidney Diseases | 3 | 2023 | 2145 | 0.410 |
Why?
|
Proportional Hazards Models | 9 | 2020 | 12344 | 0.400 |
Why?
|
Pregnancy | 24 | 2024 | 29087 | 0.400 |
Why?
|
Outpatients | 2 | 2018 | 1483 | 0.400 |
Why?
|
Arthroplasty, Replacement | 1 | 2015 | 336 | 0.400 |
Why?
|
Angina, Unstable | 1 | 2016 | 926 | 0.400 |
Why?
|
Secondary Prevention | 1 | 2018 | 1520 | 0.390 |
Why?
|
Stroke Volume | 3 | 2023 | 4983 | 0.390 |
Why?
|
Benzodiazepines | 1 | 2017 | 1101 | 0.390 |
Why?
|
Hyperkalemia | 2 | 2023 | 218 | 0.380 |
Why?
|
Hemoglobins | 1 | 2017 | 1532 | 0.380 |
Why?
|
Mood Disorders | 1 | 2017 | 1106 | 0.370 |
Why?
|
Anticoagulants | 2 | 2018 | 4595 | 0.370 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2021 | 1130 | 0.370 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 367 | 0.370 |
Why?
|
Medicaid | 9 | 2018 | 2716 | 0.350 |
Why?
|
Electronic Health Records | 6 | 2021 | 4440 | 0.340 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1967 | 0.330 |
Why?
|
International Classification of Diseases | 4 | 2021 | 865 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.320 |
Why?
|
Obesity | 6 | 2022 | 12705 | 0.310 |
Why?
|
Italy | 7 | 2019 | 828 | 0.310 |
Why?
|
Retrospective Studies | 20 | 2024 | 77098 | 0.310 |
Why?
|
Antidepressive Agents | 2 | 2017 | 2838 | 0.310 |
Why?
|
Ambulatory Care | 1 | 2018 | 2706 | 0.300 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2276 | 0.290 |
Why?
|
Postoperative Complications | 4 | 2016 | 15244 | 0.280 |
Why?
|
Treatment Outcome | 17 | 2023 | 62966 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 9941 | 0.280 |
Why?
|
Inpatients | 4 | 2024 | 2495 | 0.270 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2156 | 0.270 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2023 | 88 | 0.270 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 2 | 2016 | 104 | 0.260 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2016 | 1461 | 0.260 |
Why?
|
Clinical Coding | 2 | 2017 | 171 | 0.260 |
Why?
|
Delivery of Health Care | 6 | 2024 | 5304 | 0.250 |
Why?
|
Insulin | 5 | 2024 | 6575 | 0.250 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2016 | 1457 | 0.250 |
Why?
|
Risk Assessment | 12 | 2021 | 23320 | 0.240 |
Why?
|
Adolescent | 17 | 2024 | 85649 | 0.240 |
Why?
|
Matched-Pair Analysis | 2 | 2021 | 288 | 0.240 |
Why?
|
Adrenal Cortex Hormones | 4 | 2016 | 1847 | 0.240 |
Why?
|
Anaphylaxis | 2 | 2022 | 746 | 0.230 |
Why?
|
Violence | 1 | 2010 | 908 | 0.230 |
Why?
|
Bipolar Disorder | 2 | 2019 | 5024 | 0.230 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2370 | 0.230 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1668 | 0.220 |
Why?
|
Aged, 80 and over | 17 | 2023 | 57683 | 0.220 |
Why?
|
Time Factors | 8 | 2020 | 40054 | 0.210 |
Why?
|
Glucagon-Like Peptides | 2 | 2020 | 124 | 0.210 |
Why?
|
Neprilysin | 2 | 2023 | 439 | 0.210 |
Why?
|
Young Adult | 18 | 2019 | 56350 | 0.210 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1218 | 0.200 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2021 | 85 | 0.200 |
Why?
|
Pre-Eclampsia | 3 | 2020 | 1196 | 0.200 |
Why?
|
Phentermine | 1 | 2021 | 33 | 0.200 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2020 | 279 | 0.190 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 61 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3915 | 0.190 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2016 | 3038 | 0.190 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7153 | 0.180 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 139 | 0.180 |
Why?
|
Diabetes, Gestational | 2 | 2021 | 1184 | 0.180 |
Why?
|
Administration, Oral | 2 | 2018 | 3913 | 0.180 |
Why?
|
Contracts | 1 | 2020 | 60 | 0.180 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2023 | 436 | 0.180 |
Why?
|
Heart Failure, Systolic | 1 | 2021 | 124 | 0.180 |
Why?
|
Drug Evaluation | 1 | 2021 | 637 | 0.180 |
Why?
|
Biological Products | 3 | 2019 | 856 | 0.180 |
Why?
|
Fenofibrate | 1 | 2020 | 88 | 0.170 |
Why?
|
Longitudinal Studies | 3 | 2020 | 13921 | 0.170 |
Why?
|
Suicide | 1 | 2010 | 1475 | 0.170 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 207 | 0.170 |
Why?
|
Prevalence | 5 | 2021 | 15194 | 0.170 |
Why?
|
Peritonitis | 1 | 2021 | 365 | 0.170 |
Why?
|
Pemphigoid, Bullous | 1 | 2020 | 108 | 0.170 |
Why?
|
Peptides | 2 | 2022 | 4392 | 0.170 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2023 | 923 | 0.170 |
Why?
|
Data Interpretation, Statistical | 2 | 2021 | 2714 | 0.160 |
Why?
|
Premature Birth | 3 | 2020 | 1713 | 0.160 |
Why?
|
PPAR alpha | 1 | 2020 | 196 | 0.160 |
Why?
|
Depression | 2 | 2017 | 7733 | 0.160 |
Why?
|
Coronary Disease | 1 | 2013 | 6078 | 0.160 |
Why?
|
Ondansetron | 1 | 2018 | 89 | 0.160 |
Why?
|
Seizures | 3 | 2021 | 2851 | 0.160 |
Why?
|
Health Planning | 1 | 2019 | 237 | 0.160 |
Why?
|
Nephrology | 1 | 2021 | 260 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 440 | 0.150 |
Why?
|
Drug Labeling | 1 | 2019 | 231 | 0.150 |
Why?
|
Infant, Newborn | 11 | 2019 | 25575 | 0.150 |
Why?
|
Prescriptions | 2 | 2017 | 387 | 0.150 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39004 | 0.150 |
Why?
|
Liver Cirrhosis | 3 | 2023 | 1864 | 0.150 |
Why?
|
Antirheumatic Agents | 2 | 2018 | 1335 | 0.150 |
Why?
|
Comorbidity | 4 | 2020 | 10372 | 0.150 |
Why?
|
Antiemetics | 1 | 2018 | 176 | 0.150 |
Why?
|
Steroids | 1 | 2022 | 931 | 0.150 |
Why?
|
Antimanic Agents | 2 | 2019 | 522 | 0.150 |
Why?
|
Postoperative Period | 2 | 2021 | 1839 | 0.150 |
Why?
|
Drug Utilization Review | 1 | 2018 | 245 | 0.140 |
Why?
|
Medication Adherence | 2 | 2022 | 2055 | 0.140 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15056 | 0.140 |
Why?
|
Pregnant Women | 2 | 2021 | 566 | 0.140 |
Why?
|
Amphetamine | 1 | 2017 | 225 | 0.140 |
Why?
|
Haloperidol | 1 | 2018 | 397 | 0.140 |
Why?
|
Candidiasis | 1 | 2018 | 365 | 0.130 |
Why?
|
Age Factors | 6 | 2020 | 18355 | 0.130 |
Why?
|
Nausea | 1 | 2018 | 665 | 0.130 |
Why?
|
Algorithms | 6 | 2021 | 13853 | 0.130 |
Why?
|
Triazines | 1 | 2017 | 316 | 0.130 |
Why?
|
Hypolipidemic Agents | 1 | 2020 | 604 | 0.130 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2015 | 79 | 0.130 |
Why?
|
Endpoint Determination | 1 | 2018 | 600 | 0.130 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 983 | 0.130 |
Why?
|
Sentinel Surveillance | 1 | 2017 | 281 | 0.120 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2018 | 469 | 0.120 |
Why?
|
Bradycardia | 1 | 2016 | 305 | 0.120 |
Why?
|
Spondylitis, Ankylosing | 1 | 2016 | 155 | 0.120 |
Why?
|
Postpartum Hemorrhage | 1 | 2018 | 258 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2900 | 0.120 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2016 | 501 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 2 | 2020 | 3770 | 0.120 |
Why?
|
Incidence | 5 | 2020 | 20928 | 0.120 |
Why?
|
Morphine | 2 | 2016 | 657 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 848 | 0.120 |
Why?
|
Scopolamine Derivatives | 1 | 2013 | 23 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 2 | 2016 | 740 | 0.120 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2021 | 1016 | 0.120 |
Why?
|
Registries | 2 | 2021 | 8077 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1533 | 0.120 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 430 | 0.120 |
Why?
|
Delayed-Action Preparations | 2 | 2015 | 965 | 0.120 |
Why?
|
Cleft Lip | 1 | 2018 | 476 | 0.110 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14720 | 0.110 |
Why?
|
Methylphenidate | 1 | 2017 | 473 | 0.110 |
Why?
|
Arthritis, Rheumatoid | 3 | 2019 | 3695 | 0.110 |
Why?
|
Epidemiology | 1 | 2016 | 287 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 215 | 0.110 |
Why?
|
Gout | 1 | 2020 | 556 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20086 | 0.110 |
Why?
|
Enzyme Induction | 1 | 2013 | 475 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2020 | 827 | 0.110 |
Why?
|
Methadone | 1 | 2015 | 306 | 0.110 |
Why?
|
Hospitals, Rural | 1 | 2014 | 172 | 0.110 |
Why?
|
Analgesia, Epidural | 1 | 2016 | 326 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 886 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 848 | 0.110 |
Why?
|
Psychotic Disorders | 2 | 2018 | 3040 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2021 | 21719 | 0.110 |
Why?
|
Electroencephalography | 3 | 2022 | 6142 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2059 | 0.110 |
Why?
|
Hospitals, Urban | 1 | 2014 | 499 | 0.100 |
Why?
|
Hypertension | 5 | 2020 | 8455 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 689 | 0.100 |
Why?
|
Adrenergic beta-Agonists | 1 | 2013 | 346 | 0.100 |
Why?
|
Primary Health Care | 2 | 2019 | 4551 | 0.100 |
Why?
|
Congenital Abnormalities | 1 | 2017 | 707 | 0.100 |
Why?
|
Analgesia | 1 | 2016 | 459 | 0.100 |
Why?
|
Pain | 2 | 2017 | 4961 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3502 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2018 | 595 | 0.100 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2013 | 419 | 0.100 |
Why?
|
Infant, Newborn, Diseases | 1 | 2016 | 580 | 0.100 |
Why?
|
Sex Factors | 3 | 2020 | 10392 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10943 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 21596 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2022 | 2229 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1517 | 0.090 |
Why?
|
Fetal Diseases | 1 | 2015 | 903 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2021 | 1794 | 0.090 |
Why?
|
Abdomen | 1 | 2016 | 1107 | 0.090 |
Why?
|
Perioperative Period | 1 | 2011 | 256 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2016 | 961 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1484 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1179 | 0.090 |
Why?
|
Patient Selection | 1 | 2021 | 4214 | 0.090 |
Why?
|
Central Nervous System | 1 | 2017 | 1354 | 0.090 |
Why?
|
Hemorrhage | 2 | 2018 | 3461 | 0.090 |
Why?
|
Analgesics | 1 | 2016 | 1037 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2640 | 0.080 |
Why?
|
Delirium | 2 | 2017 | 1608 | 0.080 |
Why?
|
Logistic Models | 4 | 2017 | 13403 | 0.080 |
Why?
|
Mortality | 2 | 2021 | 2857 | 0.080 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4929 | 0.070 |
Why?
|
Abruptio Placentae | 2 | 2019 | 118 | 0.070 |
Why?
|
Preoperative Care | 1 | 2016 | 2245 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2016 | 1575 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4414 | 0.070 |
Why?
|
Recurrence | 1 | 2018 | 8333 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 3656 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3067 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2017 | 2026 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2019 | 12017 | 0.060 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2337 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2017 | 2130 | 0.060 |
Why?
|
Risperidone | 2 | 2018 | 383 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8297 | 0.060 |
Why?
|
Fetal Growth Retardation | 2 | 2019 | 570 | 0.060 |
Why?
|
Accidents, Occupational | 1 | 2006 | 251 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5100 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9581 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4147 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12695 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2099 | 0.060 |
Why?
|
Administration, Inhalation | 2 | 2016 | 1104 | 0.060 |
Why?
|
Receptors, Angiotensin | 1 | 2023 | 142 | 0.060 |
Why?
|
Kidney | 3 | 2023 | 7167 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 2 | 2015 | 571 | 0.050 |
Why?
|
Heart Failure, Diastolic | 1 | 2023 | 69 | 0.050 |
Why?
|
Silicates | 1 | 2022 | 42 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2167 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 3649 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2014 | 3584 | 0.050 |
Why?
|
Epilepsy | 1 | 2017 | 3301 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7901 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 3526 | 0.050 |
Why?
|
Minerals | 1 | 2023 | 275 | 0.050 |
Why?
|
Statistics as Topic | 2 | 2018 | 2372 | 0.050 |
Why?
|
Asia | 1 | 2023 | 607 | 0.050 |
Why?
|
Methods | 1 | 2021 | 1128 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9846 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15494 | 0.050 |
Why?
|
Medication Therapy Management | 1 | 2021 | 127 | 0.050 |
Why?
|
Glipizide | 1 | 2020 | 47 | 0.050 |
Why?
|
Schizophrenia | 1 | 2019 | 6874 | 0.050 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2043 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2566 | 0.040 |
Why?
|
Infant | 3 | 2017 | 35070 | 0.040 |
Why?
|
Bayes Theorem | 2 | 2018 | 2303 | 0.040 |
Why?
|
Phosphates | 1 | 2023 | 786 | 0.040 |
Why?
|
Prospective Studies | 3 | 2021 | 53187 | 0.040 |
Why?
|
Ascites | 1 | 2021 | 344 | 0.040 |
Why?
|
Drug Combinations | 2 | 2015 | 1961 | 0.040 |
Why?
|
Selection Bias | 1 | 2021 | 369 | 0.040 |
Why?
|
Drug Substitution | 1 | 2021 | 281 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2795 | 0.040 |
Why?
|
Spain | 1 | 2019 | 465 | 0.040 |
Why?
|
Child | 4 | 2023 | 77478 | 0.040 |
Why?
|
Mental Disorders | 1 | 2017 | 6587 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1265 | 0.040 |
Why?
|
Medical Record Linkage | 1 | 2018 | 284 | 0.040 |
Why?
|
Drug and Narcotic Control | 1 | 2018 | 146 | 0.040 |
Why?
|
Labetalol | 1 | 2016 | 30 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2017 | 192 | 0.040 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2017 | 189 | 0.040 |
Why?
|
Lisinopril | 1 | 2016 | 54 | 0.040 |
Why?
|
Atenolol | 1 | 2016 | 100 | 0.030 |
Why?
|
Metoprolol | 1 | 2016 | 93 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3339 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2020 | 676 | 0.030 |
Why?
|
Vomiting | 1 | 2018 | 632 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 954 | 0.030 |
Why?
|
Computer Simulation | 2 | 2019 | 6191 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 691 | 0.030 |
Why?
|
Polymers | 1 | 2022 | 1618 | 0.030 |
Why?
|
Insurance, Health | 2 | 2018 | 2493 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1737 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2016 | 365 | 0.030 |
Why?
|
Public Opinion | 1 | 2018 | 477 | 0.030 |
Why?
|
Policy | 1 | 2017 | 504 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2017 | 1003 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2006 | 2400 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1123 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1369 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2016 | 408 | 0.030 |
Why?
|
Bone and Bones | 1 | 2023 | 2575 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 934 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13256 | 0.030 |
Why?
|
Adiposity | 1 | 2021 | 1806 | 0.020 |
Why?
|
Government Regulation | 1 | 2016 | 522 | 0.020 |
Why?
|
Opiate Substitution Treatment | 1 | 2015 | 404 | 0.020 |
Why?
|
Thiazoles | 1 | 2018 | 1484 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2020 | 2414 | 0.020 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2016 | 485 | 0.020 |
Why?
|
Gestational Age | 1 | 2019 | 3490 | 0.020 |
Why?
|
Creatinine | 1 | 2016 | 1916 | 0.020 |
Why?
|
Prognosis | 2 | 2023 | 29010 | 0.020 |
Why?
|
Lower Extremity | 1 | 2018 | 1151 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3800 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1581 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2016 | 685 | 0.020 |
Why?
|
Medical Audit | 1 | 2011 | 467 | 0.020 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1148 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3300 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3302 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2749 | 0.020 |
Why?
|
Warfarin | 1 | 2016 | 1493 | 0.020 |
Why?
|
Piperazines | 1 | 2018 | 2488 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3937 | 0.020 |
Why?
|
Decision Making | 1 | 2020 | 3869 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6452 | 0.020 |
Why?
|
Hepatitis C | 1 | 2016 | 1582 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12946 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9826 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2011 | 979 | 0.020 |
Why?
|
Software | 1 | 2018 | 4434 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1788 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6294 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4279 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19862 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4250 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 24913 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 8969 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9305 | 0.010 |
Why?
|
HIV Infections | 1 | 2016 | 16678 | 0.010 |
Why?
|
Child, Preschool | 1 | 2011 | 40955 | 0.010 |
Why?
|